Medicine Supply Notification: Conjugated oestrogens with medroxyprogesterone (Premique Low Dose® ) 300microgram/1.5mg modified-release tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Conjugated oestrogens with medroxyprogesterone (Premique Low Dose®) 300microgram/1.5mg modified-release tablets.

MSN/2022/039

Tier 2 – medium impact

Date of issue 3rd May 2022

  • Conjugated oestrogens with medroxyprogesterone (Premique Low Dose®) 300microgram/1.5mg modified-release tablets is experiencing intermittent supply issues until late May 2022.
  •  A Serious Shortage Protocol (SSP) was issued on 29/04/2022.
  • Alternative hormone replacement therapies remain available

A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

Capture healthcare advisory work not being covered by Pharmacy First to inform our negotiations with Government and NHS.

Click Here